VIP and immune cell modulation VIP interacts with multiple immune cells through specific receptors (VPAC-1, VPAC-2, CRTH2, and PAC1) expressed on eosinophils, mast cells, neutrophils, lymphocytes, dendritic cells, NK cells, and macrophages
More than $2 billion in announced investments across at least ten major CDMOs is adding tens of thousands of liters of solid-phase peptide synthesis capacity in the United States, Europe, and Asia
Statements Author contributions XH: Data curation, Formal Analysis, Writing original draft
Single vs Split Dosing Given BPC-157s short half-life (less than 30 minutes), some users prefer splitting their daily dose into two administrations
Traditional subcutaneous needle sizes extend up to 12.7 mm